Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination.
about
Tuberculosis vaccines and prevention of infectionMycobacterium bovis Infection of Cattle and White-Tailed Deer: Translational Research of Relevance to Human TuberculosisAccelerating tuberculosis vaccine trials with diagnostic and prognostic biomarkers.Generation of Monoclonal Antibodies against Ag85A Antigen of Mycobacterium tuberculosis and Application in a Competitive ELISA for Serodiagnosis of Bovine Tuberculosis.Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosis.Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults.Tuberculosis vaccine development: Shifting focus amid increasing development challenges.Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol InfectionOptimization of a Human Bacille Calmette-Guérin Challenge Model: A Tool to Evaluate Antimycobacterial Immunity.A review of clinical models for the evaluation of human TB vaccines.Human biomarkers: can they help us to develop a new tuberculosis vaccine?TB vaccine development: where are we and why is it so difficult?Gene expression and cytokine profile correlate with mycobacterial growth in a human BCG challenge model.Tuberculosis vaccines - perspectives from the NIH/NIAID Mycobacteria vaccine testing program.What Have We Learnt about BCG Vaccination in the Last 20 Years?Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle.Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines.Progress and challenges in TB vaccine development.
P2860
Q26782022-141F8552-A5C1-4FCC-90C3-E7F07D56040BQ28083909-96EF39E3-C707-4F42-B678-D54A577403F3Q30403003-1B78EFE5-5685-4DDF-8D89-BA71DFD2A9B1Q33857535-91382C83-F4E8-4288-99A2-90573E9DB05CQ34146613-6D1B6F5B-BAA6-4FA1-95F5-1DC8307049C7Q35773915-E4BA8866-68D8-42D1-958C-653E2A9D500AQ36256304-722142AB-00D4-40A9-BD62-2C3AA2ADF49FQ36511211-6775A75B-F02F-4E74-A5E6-9F516BFC3359Q36562820-19C2A412-7D7A-456D-91AD-15F97476138EQ38711772-8D34A0E1-966E-461B-8631-3056EFFE610AQ38839838-E9785ECD-F116-41AC-96B0-658B6252C422Q39092983-52CB647B-6E1E-422C-9958-43B93C73645FQ39497862-73D99D86-B659-434F-8989-0698B1375ECBQ40116835-964952F1-2796-4B53-AA02-6EC25E3CFF2CQ41684091-F47E2EED-E1E0-49AA-9B3F-CD27FB5CA27DQ42088558-AB41BC4C-9586-49A3-A21B-A6FB18E6D49DQ51742073-7BE7A4F2-607C-4CC4-B16C-141C683A6652Q52641498-E56330D0-FC7D-4FC2-932B-18E6880F751D
P2860
Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Evaluation of a human BCG chal ...... 85A, alone and in combination.
@en
Evaluation of a human BCG chal ...... 85A, alone and in combination.
@nl
type
label
Evaluation of a human BCG chal ...... 85A, alone and in combination.
@en
Evaluation of a human BCG chal ...... 85A, alone and in combination.
@nl
prefLabel
Evaluation of a human BCG chal ...... 85A, alone and in combination.
@en
Evaluation of a human BCG chal ...... 85A, alone and in combination.
@nl
P2093
P2860
P50
P356
P1476
Evaluation of a human BCG chal ...... 85A, alone and in combination.
@en
P2093
Ian D Poulton
Iman Satti
Joel Meyer
Leanne Marsay
Rachel Tanner
Stephanie A Harris
P2860
P304
P356
10.1093/INFDIS/JIT647
P407
P577
2013-11-23T00:00:00Z